Can secret commercial activity be considered “on sale” under AIA?

Yes, secret commercial activity can be considered “on sale” under AIA 35 U.S.C. 102(a)(1). The MPEP references the Supreme Court decision in Helsinn Healthcare S.A. v. Teva Pharmaceuticals USA, Inc., stating: “[T]he Supreme Court ‘determine[d] that Congress did not alter the meaning of ‘on sale’ when it enacted the AIA, [and held] that an inventor’s…

Read More

Does the enablement inquiry apply to “on sale” determinations under AIA?

No, the enablement inquiry does not apply to “on sale” determinations under AIA 35 U.S.C. 102(a)(1). This interpretation is consistent with pre-AIA law. The MPEP states: “[T]he enablement inquiry is not applicable to the question of whether a claimed invention is ‘on sale’ under pre-AIA 35 U.S.C. 102(b).” Since the AIA’s “on sale” provision is…

Read More

What is the difference between ‘on sale’ and ‘public use’ in patent law?

While both ‘on sale’ and ‘public use’ are forms of prior art in patent law, they have distinct characteristics. According to MPEP 2152.02(d) and related sections: On Sale: Refers to commercial activities involving the invention, such as offers for sale or actual sales. It doesn’t necessarily require the invention to be publicly visible or used.…

Read More

How does the AIA’s “on sale” provision differ from pre-AIA law?

While the AIA’s “on sale” provision is largely interpreted similarly to pre-AIA law, there are some key differences. The MPEP highlights two main distinctions: Geographic limitations: “Under AIA 35 U.S.C. 102(a)(1), there is no geographic limitation on where the sale or offer for sale may occur.” This contrasts with pre-AIA law, which limited “on sale”…

Read More